Overview

Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether high doses of pralidoxime(PAM) are effective as compare to lower doses of PAM in the management of moderately sever organophosphorus poisoning patients.
Phase:
N/A
Details
Lead Sponsor:
Giriraj Hospital
Treatments:
Pralidoxime